Continuous glucose monitoring devices are used for monitoring glucose levels in patients with diabetes. These devices help in detecting glucose levels under the skin through a tiny sensor inserted subcutaneously and transmitting data to a receiver. This constant monitoring helps patients and healthcare providers make better therapeutic decisions. The global continuous glucose monitoring devices market is gaining traction owing to growing adoption of remote monitoring systems for diabetes care.

The global continuous glucose monitoring devices Market is estimated to be valued at US$ 2.9 Mn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
The opportunity for remote patient monitoring is expected to drive the continuous glucose monitoring devices market during the forecast period. Remote monitoring allows physicians to track a patient's glucose levels and other health metrics from anywhere via digital platforms. This eliminates the need for frequent in-person visits and helps manage diabetes more efficiently. The ongoing COVID-19 pandemic has further increased the need for remote solutions, thereby promoting the adoption of remote CGM systems. Integrating continuous glucose monitors with telehealth capabilities can help improve patient outcomes through proactive interventions based on real-time data analysis. This is expected to boost the demand for continuous glucose monitoring devices.

Porter's Analysis
Threat of new entrants: Low due to high capital requirements. Regulatory procedure will also bar new players.
Bargaining power of buyers: Moderate as buyers go for quality and innovation. Brand loyalty is also high.
Bargaining power of suppliers: High as few vendors exist for key raw materials. Supply chain disruptions will impact business continuity.
Threat of new substitutes: Low as CGMs offer real-time monitoring. Alternatives lack accuracy and convenience.
Competitive rivalry: High due to technological innovations. Pricing pressure exists to gain market share.

SWOT Analysis
Strengths: Continuous monitoring offers flexibility. Growing diabetic population provides market opportunity.
Weaknesses: High setup costs limits adoption. Calibration needs expertise.
Opportunities: Emerging economies with increasing healthcare spends will drive growth. Remote monitoring capabilities through apps support.
Threats: Reimbursement policies vary globally. Data privacy regulations impact operational design.

Key Takeaways
The Global Continuous Glucose Monitoring Devices Market Demand is expected to witness high, supported by rising diabetes prevalence, geriatric population and benefits offered.

Regional Analysis: The North America region currently dominates the market due to supportive regulatory environment and reimbursement policies.

The United States accounts for the largest share in the North America region owing to presence of advanced healthcare infrastructure and awareness regarding CGM devices. Increasing insurance coverage for diabetes management technologies also supplements the growth of continuous glucose monitoring devices market in the country.

Key players operating in the continuous glucose monitoring devices market are 3M, BSN Medical, Sigvaris AG, Cardinal Health, Medi GmbH & Co, ArjoHuntleigh Healthcare India, Bio Compression Systems Inc, Zimmer Biomet India, Spectrum Healthcare and Vissco Healthcare. These players focus on new product launches and enhancing service portfolio to strengthen market presence.
 

Get more insights on this topic: https://www.newsstatix.com/continuous-glucose-monitoring-device-market-size-and-share-analysis-growth-trends-and-forecasts-2023-2030/